Anteotech
Anteotech Ltd specializes in the development and commercialization of advanced medical diagnostics and energy storage solutions, leveraging its proprietary nanotechnology platform. It operates in healthcare and energy sectors, aiming for a significant market position through innovative solutions such as its proprietary AnteoBind™ technology, which enhances the sensitivity and performance of diagnostic assays.
Short position
Anteotech (ASX:ADO) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 1,321 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.56% in February 2026. ADO is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4ADO community
Research Threads
Bull, bear, catalyst, and news-reaction posts tied directly to ADO.
Start the first ADO research thread
Anchor the conversation with a thesis, a catalyst, or a question worth debating.